4.3 Article Proceedings Paper

Reflections on the tissue kallikrein and kallikrein-related peptidase family - from mice to men - what have we learnt in the last two decades?

期刊

BIOLOGICAL CHEMISTRY
卷 389, 期 12, 页码 1447-1454

出版社

WALTER DE GRUYTER GMBH
DOI: 10.1515/BC.2008.174

关键词

expression; function; gene clusters; glandular kallikrein (GK); hormonal regulation; kallikrein-related (KLK)

向作者/读者索取更多资源

The genes encoding the kininogenase, glandular tissue kallikrein, in rodents and man were first described in the mid-1980s. Remarkably, they appeared to be part of a much larger highly conserved family of genes (GK) in rodents, but only had two paralogs in man. This discrepancy was not rectified until the late 1990s/2000 with the identification of a cluster of 12 more kallikrein-related (KLK) genes in the human 19q13 locus and the subsequent identification of their rodent homologs. Interestingly, there are remarkable similarities in expression patterns, hormonal regulation and functional attributes of the old (GK) and new (KLK) families which underscore the evolutionary conservation across these loci and species. This historical perspective focuses on the lessons learned from earlier studies on the rodent GK gene families and the striking similarities of some attributes, yet uniqueness, of others. These earlier findings have all contributed to the current status of the KLK serine peptidase-encoding gene family as an exciting source of new biomarkers and therapeutic targets.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Cell Biology

Assays for Qualification and Quality Stratification of Clinical Biospecimens Used in Research: A Technical Report from the ISBER Biospecimen Science Working Group

Fay Betsou, Alexandre Bulla, Sang Yun Cho, Judith Clements, Rodrigo Chuaqui, Domenico Coppola, Yvonne De Souza, Annemieke De Wilde, William Grizzle, Fiorella Guadagni, Elaine Gunter, Stacey Heil, Verity Hodgkinson, Joseph Kessler, Michael Kiehntopf, Hee Sung Kim, Iren Koppandi, Katheryn Shea, Rajeev Singh, Marc Sobel, Stella Somiari, Demetri Spyropoulos, Mars Stone, Gunnel Tybring, Klara Valyi-Nagy, Gert Van den Eynden, Lalita Wadhwa

BIOPRESERVATION AND BIOBANKING (2016)

Review Biochemical Research Methods

Mass spectrometry based proteomics analyses in kallikrein-related peptidase research: implications for cancer research and therapy

Lakmali Munasinghage Silva, Judith Ann Clements

EXPERT REVIEW OF PROTEOMICS (2017)

Article Dermatology

Selective Substrates and Inhibitors for Kallikrein-Related Peptidase 7 (KLK7) Shed Light on KLK Proteolytic Activity in the Stratum Corneum

Simon J. de Veer, Laetitia Furio, Joakim E. Swedberg, Christopher A. Munro, Maria Brattsand, Judith A. Clements, Alain Hovnanian, Jonathan M. Harris

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2017)

Article Cell & Tissue Engineering

A humanised tissue-engineered bone model allows species-specific breast cancer-related bone metastasis in vivo

V. M. C. Quent, A. V. Taubenberger, J. C. Reichert, L. C. Martine, J. A. Clements, D. W. Hutmacher, D. Loessner

JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE (2018)

Article Oncology

Kallikrein-related peptidase 4 induces cancer-associated fibroblast features in prostate-derived stromal cells

Thomas Kryza, Lakmali M. Silva, Nathalie Bock, Ruth A. Fuhrman-Luck, Carson R. Stephens, Jin Gao, Hema Samaratunga, Mitchell G. Lawrence, John D. Hooper, Ying Dong, Gail P. Risbridger, Judith A. Clements

MOLECULAR ONCOLOGY (2017)

Article Multidisciplinary Sciences

Mass spectrometry-based determination of Kallikrein-related peptidase 7 (KLK7) cleavage preferences and subsite dependency

Lakmali Munasinghage Silva, Thomas Stoll, Thomas Kryza, Carson Ryan Stephens, Marcus Lachlan Hastie, Helen Frances Irving-Rodgers, Ying Dong, Jeffrey John Gorman, Judith Ann Clements

SCIENTIFIC REPORTS (2017)

Article Food Science & Technology

Enter the Dragon: The Dynamic and Multifunctional Evolution of Anguimorpha Lizard Venoms

Ivan Koludarov, Timothy N. W. Jackson, Bianca op den Brouw, James Dobson, Daniel Dashevsky, Kevin Arbuckle, Christofer J. Clemente, Edward J. Stockdale, Chip Cochran, Jordan Debono, Carson Stephens, Nadya Panagides, Bin Li, Mary-Louise Roy Manchadi, Aude Violette, Rudy Fourmy, Iwan Hendrikx, Amanda Nouwens, Judith Clements, Paolo Martelli, Hang Fai Kwok, Bryan G. Fry

TOXINS (2017)

Article Multidisciplinary Sciences

In vitro engineering of a bone metastases model allows for study of the effects of antiandrogen therapies in advanced prostate cancer

Nathalie Bock, Thomas Kryza, Ali Shokoohmand, Joan Rohl, Akhilandeshwari Ravichandran, Marie-Luise Wille, Colleen C. Nelson, Dietmar W. Hutmacher, Judith A. Clements

Summary: The all-human microtissue-engineered model of mineralized metastatic tissue plays a crucial role in understanding the bone tumor microenvironment and treatment response in mCRPC, with enzalutamide demonstrating better therapeutic efficacy compared to bicalutamide in a mineralized microenvironment.

SCIENCE ADVANCES (2021)

Review Biochemistry & Molecular Biology

The roles of proteases in prostate cancer

Hannu Koistinen, Ruusu-Maaria Kovanen, Morley D. Hollenberg, Antoine Dufour, Evette S. Radisky, Ulf-Hakan Stenman, Jyotsna Batra, Judith Clements, John D. Hooper, Eleftherios Diamandis, Oliver Schilling, Antti Rannikko, Tuomas Mirtti

Summary: Since the proposition of the pro-invasive activity of proteolytic enzymes over 70 years ago, several roles for proteases in cancer progression have been established. About half of the 473 active human proteases are expressed in the prostate and many of the most well-characterized members of this enzyme family are regulated by androgens, hormones essential for development of prostate cancer. Most notably, several kallikrein-related peptidases, including KLK3 (prostate-specific antigen, PSA), the most well-known prostate cancer marker, and type II transmembrane serine proteases, such as TMPRSS2 and matriptase, have been extensively studied and found to promote prostate cancer progression. Recent findings also suggest a critical role for proteases in the development of advanced and aggressive castration-resistant prostate cancer (CRPC). Perhaps the most intriguing evidence for this role comes from studies showing that the protease-activated transmembrane proteins, Notch and CDCP1, are associated with the development of CRPC.

IUBMB LIFE (2023)

Article Engineering, Biomedical

GelMA and Biomimetic Culture Allow the Engineering of Mineralized, Adipose, and Tumor Tissue Human Microenvironments for the Study of Advanced Prostate Cancer In Vitro and In Vivo

Agathe Bessot, Jennifer Gunter, David Waugh, Judith A. Clements, Dietmar W. Hutmacher, Jacqui McGovern, Nathalie Bock

Summary: Increasing evidence highlights the important role of bone marrow adipocytes in prostate cancer bone metastases. However, lack of relevant models has hindered the understanding of human BM-adipocyte effects in this microenvironment. This study combines tunable GelMA-based hydrogels with biomimetic culture of human cells to engineer human bone tumor microenvironments containing BM-adipocytes. In vitro culture of human osteoprogenitors, adipocytes, and PCa cells in GelMA hydrogels leads to the formation of mineralized, adipose, and PCa tumor 3D microtissues, respectively. The stiffness of hydrogels regulates osteoblast mineralization and tumor spheroid formation, while coculture with tumor cells induces morphological changes and delipidation in BM-adipocytes. The in vivo model successfully forms a humanized fatty bone microenvironment and demonstrates that adipocytes support early bone tumor growth. This advanced platform combines natural aspects of the microenvironment with tunable properties for bone tumor research.

ADVANCED HEALTHCARE MATERIALS (2023)

Article Oncology

Characterisation of cell lines derived from prostate cancer patients with localised disease

Leire Moya, Carina Walpole, Fiona Rae, Srilakshmi Srinivasan, Inge Seim, John Lai, David Nicol, Elizabeth D. Williams, Judith A. Clements, Jyotsna Batra

Summary: This study successfully established four cell lines derived from localized prostate cancer, including two benign and two malignant cell lines. The characteristics and molecular events of these cell lines could help in understanding the development and progression of cancer.

PROSTATE CANCER AND PROSTATIC DISEASES (2023)

Review Oncology

Genomic and Phenotypic Biomarkers for Precision Medicine Guidance in Advanced Prostate Cancer

Fatemeh Davoudi, Afshin Moradi, Therese M. M. Becker, John G. G. Lock, Brian Abbey, Davide Fontanarosa, Annette Haworth, Judith Clements, Rupert C. C. Ecker, Jyotsna Batra

Summary: Prostate cancer is a commonly diagnosed malignant neoplasm and a leading cause of cancer-related death in men worldwide. Personalized therapeutic strategies for this disease remain limited, but emerging biomarkers based on individual patient profiles and computer-assisted diagnostics have the potential to guide precision medicine. This review discusses screening methods, genetic aberrations, and phenotypic biomarkers for advanced prostate cancer, exploring their clinical implications in diagnosis, prognosis, and treatment prediction. Prognostic and treatment predictive biomarker discovery can improve patient management and personalized treatment regimens.

CURRENT TREATMENT OPTIONS IN ONCOLOGY (2023)

Review Oncology

Remodelling of the tumour microenvironment by the kallikrein-related peptidases

Srilakshmi Srinivasan, Thomas Kryza, Jyotsna Batra, Judith Clements

Summary: This review discusses the complex biology of kallikrein-related peptidases and their role in cancer and the tumor microenvironment. It also explores their involvement in tumor immune suppression and resistance to cancer therapy. Understanding the functions of these peptidases can provide insights into tumor development and help in developing new therapeutic strategies.

NATURE REVIEWS CANCER (2022)

Article Oncology

Lycopene reduces ovarian tumor growth and intraperitoneal metastatic load

Nina Pauline Holzapfel, Ali Shokoohmand, Ferdinand Wagner, Marietta Landgraf, Simon Champ, Boris Michael Holzapfel, Judith Ann Clements, Dietmar Werner Hutmacher, Daniela Loessner

AMERICAN JOURNAL OF CANCER RESEARCH (2017)

Article Oncology

Height, selected genetic markers and prostate cancer risk: results from the PRACTICAL consortium

Artitaya Lophatananon, Sarah Stewart-Brown, Zsofia Kote-Jarai, Ali Amin Al Olama, Sara Benlloch Garcia, David E. Neal, Freddie C. Hamdy, Jenny L. Donovan, Graham G. Giles, Liesel M. Fitzgerald, Melissa C. Southey, Paul Pharoah, Nora Pashayan, Henrik Gronberg, Fredrik Wiklund, Markus Aly, Janet L. Stanford, Hermann Brenner, Aida K. Dieffenbach, Volker Arndt, Jong Y. Park, Hui-Yi Lin, Thomas Sellers, Chavdar Slavov, Radka Kaneva, Vanio Mitev, Jyotsna Batra, Amanda Spurdle, Judith A. Clements, Douglas Easton, Rosalind A. Eeles, Kenneth Muir

BRITISH JOURNAL OF CANCER (2017)

暂无数据